Cargando…
Serum N-glycomic profiling may provide potential signatures for surveillance of COVID-19
Disease development and progression are often associated with aberrant glycosylation, indicating that changes in biological fluid glycome may potentially serve as disease signatures. The corona virus disease-2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV...
Autores principales: | Xie, Yongjing, Butler, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487901/ https://www.ncbi.nlm.nih.gov/pubmed/35925863 http://dx.doi.org/10.1093/glycob/cwac051 |
Ejemplares similares
-
Serum N‐Glycome analysis reveals pancreatic cancer disease signatures
por: Vreeker, Gerda C. M., et al.
Publicado: (2020) -
Glycomic Signatures on Serum IgGs for Prediction of Postvaccination Response
por: Wang, Jing-Rong, et al.
Publicado: (2015) -
Comparison of the methods for profiling N-glycans—hepatocellular carcinoma serum glycomics study
por: Wang, Ran, et al.
Publicado: (2018) -
Serum immunoglobulin G N-glycome: a potential biomarker in endometrial cancer
por: Lin, Sihan, et al.
Publicado: (2020) -
Serum N-Glycome Diversity in Teleost and Chondrostrean Fishes
por: Aoki, Kazuhiro, et al.
Publicado: (2021)